Literature DB >> 23259987

Correlation between cytokine levels and changes in fatigue and quality of life in patients with acute myeloid leukemia.

Filgen Y Fung1, Madeline Li, Henriette Breunis, Narhari Timilshina, Mark D Minden, Shabbir M H Alibhai.   

Abstract

Cancer-related fatigue (CRF) is a major problem in patients with acute myeloid leukemia (AML) and may be mediated by circulating cytokines. We examined this relationship in 74 adult AML patients before and after the first cycle of induction chemotherapy. Plasma levels of 13 cytokines were measured via electrochemiluminescence. At baseline, potentially clinically important (r>0.30) correlations were seen between tumor necrosis factor (TNF)-α and fatigue (r=-0.336, p=0.017). Over time, correlations with fatigue were noted with TNF-α (r=-0.341, p=0.006) and interferon-inducible protein (IP)-10 (r=0.353, p=0.005). The link between IP-10 and fatigue is novel, implicating CXC chemokine pathways for CRF in hematologic malignancies.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23259987     DOI: 10.1016/j.leukres.2012.11.013

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  20 in total

Review 1.  The biology of cancer-related fatigue: a review of the literature.

Authors:  Leorey N Saligan; Karin Olson; Kristin Filler; David Larkin; Fiona Cramp; Sriram Yennurajalingam; Yennu Sriram; Carmen P Escalante; Auro del Giglio; Kord M Kober; Jayesh Kamath; Oxana Palesh; Karen Mustian
Journal:  Support Care Cancer       Date:  2015-05-15       Impact factor: 3.603

2.  Cytokine polymorphisms are associated with fatigue in adults living with HIV/AIDS.

Authors:  Kathryn A Lee; Caryl L Gay; Anners Lerdal; Clive R Pullinger; Bradley E Aouizerat
Journal:  Brain Behav Immun       Date:  2014-03-12       Impact factor: 7.217

3.  Inflammatory biomarkers and patient-reported outcomes in acute myeloid leukemia: Refocusing on older adults.

Authors:  Li-Wen Huang; Rebecca L Olin
Journal:  J Geriatr Oncol       Date:  2019-07-23       Impact factor: 3.599

Review 4.  Fitness in the elderly: how to make decisions regarding acute myeloid leukemia induction.

Authors:  Arati V Rao
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

5.  Cell autonomous expression of CXCL-10 in JAK2V617F-mutated MPN.

Authors:  Tina M Schnöder; Judith Eberhardt; Michael Koehler; Holger B Bierhoff; Sönke Weinert; Akhilesh Datt Pandey; Subbaiah Chary Nimmagadda; Denise Wolleschak; Korinna Jöhrens; Thomas Fischer; Florian H Heidel
Journal:  J Cancer Res Clin Oncol       Date:  2017-02-23       Impact factor: 4.553

6.  A clinically translatable mouse model for chemotherapy-related fatigue.

Authors:  Jonathan A Zombeck; Edward G Fey; Gregory D Lyng; Stephen T Sonis
Journal:  Comp Med       Date:  2013       Impact factor: 0.982

7.  Adult Acute Myeloid Leukemia Long-term Survivors.

Authors:  M Jennifer Cheng; Christopher S Hourigan; Thomas J Smith
Journal:  J Leuk (Los Angel)       Date:  2014-04-10

8.  The impact of inflammation and cytokine expression of PM2.5 in AML.

Authors:  Tingting Chen; Juan Zhang; Hui Zeng; Yue Zhang; Yong Zhang; Xiaohuan Zhou; Dong Zhao; Yingmei Feng; Hebing Zhou
Journal:  Oncol Lett       Date:  2018-06-13       Impact factor: 2.967

9.  Inflammatory biomarkers, geriatric assessment, and treatment outcomes in acute myeloid leukemia.

Authors:  Kah Poh Loh; Janet A Tooze; Barbara J Nicklas; Stephen B Kritchevsky; Jeff D Williamson; Leslie R Ellis; Bayard L Powell; Timothy S Pardee; Neha G Goyal; Heidi D Klepin
Journal:  J Geriatr Oncol       Date:  2019-04-05       Impact factor: 3.599

10.  Antioxidant and anti-inflammatory activity of Ocimum labiatum extract and isolated labdane diterpenoid.

Authors:  Petrina Kapewangolo; Justin J Omolo; Ronel Bruwer; Pascaline Fonteh; Debra Meyer
Journal:  J Inflamm (Lond)       Date:  2015-01-20       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.